MoonLake Immunotherapeutics (MLTX) Debt Ratio (2021)
MoonLake Immunotherapeutics' Debt Ratio history spans 1 years, with the latest figure at 1.55 for Q4 2021.
- Quarterly Debt Ratio changed N/A to 1.55 in Q4 2021 from the year-ago period, while the trailing twelve-month figure was 1.55 through Dec 2021, changed N/A year-over-year, with the annual reading at 1.55 for FY2021, N/A changed from the prior year.
- Debt Ratio came in at 1.55 for Q4 2021.
- In the past five years, Debt Ratio ranged from a high of 1.55 in Q4 2021 to a low of 1.55 in Q4 2021.